Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT04697576 2026-03-10

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Phase 1 Recruiting

36 enrolled

Dermatologic

Melanoma

NCT03026140 2026-03-05

NICHE

Phase 2 Recruiting

353 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07281924 2026-03-02

Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Phase 1/2 Recruiting

15 enrolled

Dermatologic

Melanoma

NCT06999980 2026-02-19

Neo IRENIE

Phase 2 Recruiting

494 enrolled

Dermatologic

Melanoma

NCT06151236 2026-02-17

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Phase 2 Recruiting

20 enrolled

Dermatologic

Carcinoma, Merkel Cell

NCT06624475 2026-02-05

NEON

Phase 2 Recruiting

30 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT05704647 2026-01-14

Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Phase 2 Recruiting

30 enrolled

Dermatologic

Melanoma

NCT06295159 2026-01-08

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Phase 2 Recruiting

90 enrolled

Dermatologic

Melanoma

NCT05428007 2026-01-05

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Recruiting

105 enrolled

Dermatologic

Melanoma

NCT06624644 2025-09-10

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Phase 2/3 Recruiting

135 enrolled

Dermatologic

Melanoma

NCT04205552 2024-05-09

NEOpredict

Phase 2 Recruiting

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04913922 2022-11-08

AARON

Phase 2 Recruiting

30 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute